Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-17

Clinical Trial Update: Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070) [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing 20% and 30% etoricoxib tablet formulations; completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Pain | Phase 1 | Status: COMPLETED | Results posted: 2009-11-17